Table 1.
IHC expression of ZNF703 in seventy-six triple-negative breast cancer patients
| Characteristics | Total No. |
ZNF703 Low/negative No. (%) |
ZNF703 High No. (%) |
P value b |
|---|---|---|---|---|
| Age | 76 | 0.90 | ||
| <=50 | 20 (40.0) | 10 (38.5) | ||
| >50 | 30 (60.0) | 16 (61.5) | ||
| Lymph node metastases | 61 a | 0.14 | ||
| No | 31 (75.6) | 11 (55.0) | ||
| Yes | 10 (24.4) | 9 (45.0) | ||
| Grade | 76 | 0.46 | ||
| 1 | 2 (4.0) | 3 (11.5) | ||
| 2 | 24 (48.0) | 12 (46.2) | ||
| 3 | 24 (48.0) | 11 (42.3) | ||
| Pathological type | 76 | 0.84 | ||
| IDC | 45 (90.0) | 23 (88.5) | ||
| other | 5 (10.0) | 3 (11.5) | ||
| Tumor size | 53 a | |||
| < 3 cm | 15 (40.5) | 8 (50.0) | 0.56 | |
| >= 3 cm | 22 (59.5) | 8 (50.0) | ||
| Stage | 60 a | |||
| I | 9 (22.5) | 3 (15.0) | 0.73 | |
| II/III | 31 (77.5) | 17 (85.0) |
a Missing data not calculated statistically. b P values less than 0.05 considered statistically significant